Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

5% minoxidil helps hair regrowth in androgenic alopecia.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Hair loss in women not always linked to increased oil production; other factors may be involved.

The study tested a hair treatment and found it can help grow hair, but won't stop baldness. It's safe and works well, but needs more testing.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

A teenage girl with high androgen levels and PCOS developed a rare liver tumor, suggesting a possible link between high androgens and the tumor's growth.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Substance from human umbilical cord blood cells promotes hair growth.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.